|
Q4 FY2026
As of Sep 30, 2026
|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Franklin Resources, Inc. | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total receivables | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Investments, at fair value | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total investments, at fair value | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Compensation and benefits | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total accounts payable and accrued expenses | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total debt | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total other | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable Noncontrolling Interests | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total redeemable Noncontrolling Interests | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock, $1.00 par value, 1,000,000 shares authorized; none issued | ||||||||||||||||||||
| Common stock, $0.10 par value, 1,000,000,000 shares authorized; 512,470,961 and 520,951,796 shares issued and outstanding at September 30, 2026 and 2025 | ||||||||||||||||||||
| Additional Paid in Capital, Common Stock | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Franklin Templeton, Inc. stockholders’ equity | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total Franklin Templeton, Inc. stockholders’ equity | ||||||||||||||||||||
| Nonredeemable noncontrolling interests | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total nonredeemable noncontrolling interests | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity | ||||||||||||||||||||
Loading...